May 10, 2024 | Heart, Heart disease, MedBen WellLiving, Preventive Care, Specialty Care, Wellness, Wellness exam, Wellness screenings
According to Medical Xpress, “Nine of 10 American adults are in the early, middle or late stages of a syndrome that leads to heart disease, a new report finds.” However, proactive wellness can greatly reduce the risk of developing the disease. Based on the...
Sep 5, 2023 | Alternative Reimbursement Strategies, Claims, Comparative Effectiveness, Cost Savings, Direct-to-Employer Contracting, Drug costs, Fair Market Pricing, Forensic claims review, High-cost claims, Inflation, MedBen Rx, MedBen WellLiving, Reference-Based Pricing, Rx Costs, Savings, Self-funding, Specialty Care, Survey, Wellness
A new survey by International Foundation of Employee Benefit Plans found employers expect plan costs to increase seven percent in 2024. As to why, they gave a range of answers, with the top four reasons representing 71 percent of responses (see chart below). As it...
Nov 24, 2022 | Chronic conditions, Diabetes, MedBen WellLiving, Specialty Care
Consider these stats from the Centers for Disease Control and Prevention 2022 National Diabetes Statistics Report: As of 2019, 37.3 million people (adults and children) have diagnosed diabetes (11.3% of the US population).96 million adults (aged 18 years or older)...
Jan 7, 2022 | Brand Name Drugs, Cost Savings, Generic Drugs, MedBen Rx, Prescription, Rx Costs, Savings, Specialty Care
GoodRx is currently compiling a list of drugs that will cost consumers more in 2022. By January 17, 669 drugs will have experienced price increases, with an average increase of 5.0%. All but 11 on the list are brand-name medications. The list includes such well-known...
Sep 6, 2020 | News, Preventive Care, Primary Care, Research, Specialty Care, Telehealth, Telemedicine
According to an analysis issued by The Commonwealth Fund, health care utilization has begun a slow return to pre-pandemic levels as stay-at-home restrictions have been lifted. Major findings from the research, as reported by Healthcare Dive: As of Aug. 1, all...
Sep 5, 2020 | Prescription, Research, Specialty Care
Myalept tops the list of the most expensive drugs currently sold in the United States, as compiled by GoodRx. Used to treat leptin deficiency, Myalept carries a list price of $71,306 for a 30-day prescription. Mavenclad, a multiple sclerosis treatment, follows at...
